HTLV-1 associated myelopathy in Canada.

HTLV-1 associated myelopathy in Canada.

We report the clinical and laboratory findings of six Canadian patients with progressive myelopathy associated with HTLV-1 infection. The diagnosis was suspected on clinical grounds and supported by serological studies and positive gene amplification. Only five had emigrated from an area endemic for...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Power, C, Weinshenker, BG, Dekaban, G, Ebers, G, Francis, G, Rice, G
Format:	Journal article
Język:	English
Wydane:	1989

Podobne zapisy

ABSENCE OF ANTIBODIES TO HTLV-I AND HTLV-III IN SERA OF PATIENTS WITH MS AND CHRONIC MYELOPATHY
od: Rice, G, i wsp.
Wydane: (1986)

Some clinical and pathologic observations on chronic myelopathy: a variant of multiple sclerosis.
od: Weinshenker, BG, i wsp.
Wydane: (1990)

Absence of antibody to HTLV I and III in sera of Canadian patients with multiple sclerosis and chronic myelopathy.
od: Rice, G, i wsp.
Wydane: (1986)

Effect of Pulsed Methylprednisolone on Pain, in Patients with HTLV-1-Associated Myelopathy.
od: Kevin G Buell, i wsp.
Wydane: (2016-01-01)

Plasma proteome analysis in HTLV-1-associated myelopathy/tropical spastic paraparesis.
od: Kirk, P, i wsp.
Wydane: (2011)

Aquaporin-4 antibodies are not related to HTLV-1 associated myelopathy.
od: Felipe von Glehn, i wsp.
Wydane: (2012-01-01)

Diagnostic Value of Anti-HTLV-1-Antibody Quantification in Cerebrospinal Fluid for HTLV-1-Associated Myelopathy
od: Tomoo Sato, i wsp.
Wydane: (2024-10-01)

A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis.
od: Weinshenker, BG, i wsp.
Wydane: (1992)

Remission of psoriatic lesions with muromonab-CD3 (orthoclone OKT3) treatment.
od: Weinshenker, BG, i wsp.
Wydane: (1989)

B‐cell depletion limits HTLV‐1‐infected T‐cell expansion and ameliorate HTLV‐1‐associated myelopathy
od: Aowei Lv, i wsp.
Wydane: (2024-10-01)

Susceptibility of Primary HTLV-1 Isolates from Patients with HTLV-1-Associated Myelopathy to Reverse Transcriptase Inhibitors
od: Antonio Mastino, i wsp.
Wydane: (2011-05-01)

Magnetic resonance imaging in HTLV-I associated myelopathy
od: Aílton Melo, i wsp.
Wydane: (1993-09-01)

HTLV-I associated myelopathy in salvador (northeastern Brazil)
od: A. Meireles, i wsp.
Wydane: (1992-06-01)

Galvanic vestibular stimulation for the postural rehabilitation of HTLV-1-associated myelopathy
od: Tatiana Rocha Silva, i wsp.
Wydane: (2024-12-01)

Early-Onset HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
od: Alvaro Schwalb, i wsp.
Wydane: (2020-06-01)

Diffusion tensor imaging metrics in diagnosis of HTLV‐1‐associated myelopathy
od: Sheila N. F. Liberato de Matos, i wsp.
Wydane: (2022-04-01)

Dermatologic Manifestations in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
od: Reza Boostani, i wsp.
Wydane: (2019-05-01)

Balance assessment in HTLV-1 associated myelopathy or tropical spastic paraparesis
od: Naiane Araújo Patrício, i wsp.
Wydane: (2020-11-01)

Systemic interferon alfa in multiple sclerosis.
od: Weinshenker, BG, i wsp.
Wydane: (1989)

The natural history of multiple sclerosis.
od: Weinshenker, BG, i wsp.
Wydane: (1987)

Effects of host restriction factors and the HTLV-1 subtype on susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis
od: Satoshi Nozuma, i wsp.
Wydane: (2017-04-01)

An open trial of OKT3 in patients with multiple sclerosis.
od: Weinshenker, BG, i wsp.
Wydane: (1991)

HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy.
od: Jeffery, K, i wsp.
Wydane: (1999)

Immunologic parameters of cerebrospinal fluid in HTLV-I associated myelopathy
od: Marzia Puccioni-sohler
Wydane: (1995-06-01)

Three plasma biomarkers of HTLV-1-associated myelopathy/tropical spastic paraparesis
od: Taylor Graham P, i wsp.
Wydane: (2011-06-01)

Plasma proteome analysis in HTLV-1-associated myelopathy/tropical spastic paraparesis
od: Stumpf Michael PH, i wsp.
Wydane: (2011-10-01)

Correction: Familial Clusters of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis.
od: Satoshi Nozuma, i wsp.
Wydane: (2016-01-01)

Cognitive impairment in HTLV-1-associated myelopathy, proviral load and inflammatory markers
od: Ana Paula Silva Champs, i wsp.
Wydane: (2019-07-01)

HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Is Not Associated with SNP rs12979860 of the IL-28B Gene
od: Antonio C. R. Vallinoto, i wsp.
Wydane: (2015-01-01)

EZH1/2 dual inhibitors suppress HTLV-1-infected cell proliferation and hyperimmune response in HTLV-1-associated myelopathy
od: Akihito Koseki, i wsp.
Wydane: (2023-06-01)

HTLV-1-Associated Myelopathy (HAM) Incidence in Asymptomatic Carriers and Intermediate Syndrome (IS) Patients
od: Rosa Maria do Nascimento Marcusso, i wsp.
Wydane: (2024-05-01)

Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
od: Marco Baratella, i wsp.
Wydane: (2017-01-01)

Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)
od: Yoshimi Enose-Akahata, i wsp.
Wydane: (2019-11-01)

HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Overlapping Ossification of the Ligamentum Flavum
od: Guilherme Gago, i wsp.
Wydane: (2020-09-01)

Median Nerve Somatosensory Evoked Potential in HTLV-I Associated Myelopathy
od: Reza Boostani, i wsp.
Wydane: (2016-05-01)

Caracterização molecular do HTLV-1 em pacientes com paraparesia espástica tropical/mielopatia associada ao HTLV-1 em Belém, Pará Molecular characterization of HTLV-1 among patients with tropical spastic paraparesis/HTLV-1 associated myelopathy in Belém, Pará
od: Lucinda A. Souza, i wsp.
Wydane: (2006-10-01)

The Impact of Immune Response on HTLV-I in HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
od: Houshang Rafatpanah, i wsp.
Wydane: (2013-03-01)

Use of Oral Corticosteroids to Treat HTLV-1-Associated Myelopathy (HAM) in São Paulo, Brazil
od: Flavia Esper Dahy, i wsp.
Wydane: (2023-05-01)

Upregulation of hsa-miR-125b in HTLV-1 asymptomatic carriers and HTLV-1-associated myelopathy/tropical spastic paraparesis patients
od: Larissa Deadame de Figueiredo Nicolete, i wsp.
Wydane: (2012-09-01)

Real-world clinical course of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Japan
od: Shuntaro Tsutsumi, i wsp.
Wydane: (2019-10-01)